These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3125744)

  • 61. What is the nature of the charge transfer interaction at the aldose reductase inhibitor site.
    Kador PF; Nakayama T; Sato S; Smar M; Miller DD
    Prog Clin Biol Res; 1989; 290():237-50. PubMed ID: 2498900
    [No Abstract]   [Full Text] [Related]  

  • 62. Prevention of defects of axonal transport in experimental diabetes by aldose reductase inhibitors.
    Tomlinson DR; Willars GB; Robinson JP
    Drugs; 1986; 32 Suppl 2():15-8. PubMed ID: 2431858
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
    Jacobson M; Sharma YR; Cotlier E; Hollander JD
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study.
    Datiles M; Fukui H; Kuwabara T; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):174-9. PubMed ID: 6799419
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Aldose reductase inhibitors and late complications of diabetes.
    Benfield P
    Drugs; 1986; 32 Suppl 2():43-55. PubMed ID: 3098544
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [The intraocular penetration of aldose reductase inhibitor in rat eyes].
    Kojima M; Sasaki K
    Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):57-62. PubMed ID: 3133930
    [No Abstract]   [Full Text] [Related]  

  • 67. Prevention of diabetes-related retinal microangiopathy with aldose reductase inhibitors.
    Robison WG
    Adv Exp Med Biol; 1988; 246():365-72. PubMed ID: 3150650
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Topical fibronectin in the treatment of persistent corneal epithelial defects and trophic ulcers.
    Phan TM; Foster CS; Boruchoff SA; Zagachin LM; Colvin RB
    Am J Ophthalmol; 1987 Nov; 104(5):494-501. PubMed ID: 3674183
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical trials with aldose reductase inhibitors.
    Stribling D
    Exp Eye Res; 1990 Jun; 50(6):621-4. PubMed ID: 2115450
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Corneal stromal infiltrates in patients with recurrent erosions.
    Tabery HM
    Acta Ophthalmol Scand; 1998 Oct; 76(5):589-92. PubMed ID: 9826045
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Reevaluation of corneal complications after closed vitrectomy.
    Chung H; Tolentino FI; Cajita VN; Acosta J; Refojo MF
    Arch Ophthalmol; 1988 Jul; 106(7):916-9. PubMed ID: 3390054
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Treatment of recurrent corneal erosion and corneal edema with topical osmotic colloidal solution.
    Foulks GN
    Ophthalmology; 1981 Aug; 88(8):801-3. PubMed ID: 6172765
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Diabetic keratopathy: Insights and challenges.
    Priyadarsini S; Whelchel A; Nicholas S; Sharif R; Riaz K; Karamichos D
    Surv Ophthalmol; 2020; 65(5):513-529. PubMed ID: 32092364
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical evaluation of fibronectin eyedrops on epithelial disorders after herpetic keratitis.
    Nishida T; Nakagawa S; Manabe R
    Ophthalmology; 1985 Feb; 92(2):213-6. PubMed ID: 3982800
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Migratory serpiginous corneal epitheliopathy (MSCE)- details of 4 cases.
    Mohanty A; Mittal R; Khurana A; Chanda S; Priyadarshini S; Sahu SK
    Ocul Surf; 2020 Oct; 18(4):742-747. PubMed ID: 32822834
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Compression keratopathy.
    Frazer DG; Armstrong MF; Archer DB
    Am J Ophthalmol; 1986 Aug; 102(2):208-10. PubMed ID: 3740182
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Patterns of superficial keratopathy.
    Roussel T; Grutzmacher R; Coster D
    Aust J Ophthalmol; 1984 Nov; 12(4):301-16. PubMed ID: 6442135
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The influence of a peptide sequence from PF-4 (CT-112) on type II collagen-induced arthritis in mice.
    Wooley PH; Whalen JD; Dutcher JA; Counts DF
    Inflamm Res; 1995 Aug; 44 Suppl 2():S125-6. PubMed ID: 8548360
    [No Abstract]   [Full Text] [Related]  

  • 79. Systemic tetracycline hydrochloride as adjunctive therapy in the treatment of persistent epithelial defects.
    Perry HD; Kenyon KR; Lamberts DW; Foulks GN; Seedor JA; Golub LM
    Ophthalmology; 1986 Oct; 93(10):1320-2. PubMed ID: 3785891
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Corneal mucus plaques.
    Fraunfelder FT; Wright P; Tripathi RC
    Am J Ophthalmol; 1977 Feb; 83(2):191-7. PubMed ID: 836661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.